Low-fat versus ketogenic diet in Parkinsons disease: a pilot randomized controlled trial
1 The proportion of participants reaching each weight-loss threshold: Among participants who completed the full course at the maintenance dose, average weight loss reached 16.6%
Treatments launched in the past several years by companies including Eli Lilly and an Eisai-Biogen partnership are the first drugs ever shown to slow cognitive decline in people with Alzheimer's after years of failed trials, but they require infusions or injections and can cause significant side effects.
Additionally, inflammation and dysbiosis can lead to systemic effects, contributing to chronic conditions like CKD and neuroinflammation (Adesso et al., 2017)
What peptide stack does Perfect B recommend for fat loss
Forlani from T BridgeBV Tech S.p.A and Igor Monti from Istituto di Ricerche Farmacologiche Mario Negri IRCCS who kindly assisted us with data collection